A detailed history of Oppenheimer & CO Inc transactions in Veru Inc. stock. As of the latest transaction made, Oppenheimer & CO Inc holds 397,942 shares of VERU stock, worth $282,538. This represents 0.0% of its overall portfolio holdings.

Number of Shares
397,942
Previous 535,340 25.67%
Holding current value
$282,538
Previous $449,000 31.85%
% of portfolio
0.0%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$0.77 - $1.04 $105,796 - $142,893
-137,398 Reduced 25.67%
397,942 $306,000
Q2 2024

Aug 07, 2024

BUY
$0.76 - $1.79 $397,466 - $936,137
522,982 Added 4231.93%
535,340 $449,000
Q1 2024

May 06, 2024

SELL
$0.37 - $0.72 $3,382 - $6,581
-9,141 Reduced 42.52%
12,358 $8,000
Q4 2023

Feb 13, 2024

SELL
$0.67 - $1.17 $4,602 - $8,036
-6,869 Reduced 24.21%
21,499 $15,000
Q3 2023

Nov 07, 2023

BUY
$0.72 - $1.33 $3,240 - $5,985
4,500 Added 18.85%
28,368 $20,000
Q2 2023

Aug 02, 2023

SELL
$0.98 - $1.49 $2,868 - $4,361
-2,927 Reduced 10.92%
23,868 $28,000
Q1 2023

May 10, 2023

BUY
$1.16 - $6.41 $2,623 - $14,499
2,262 Added 9.22%
26,795 $31,000
Q4 2022

Feb 07, 2023

BUY
$4.78 - $15.01 $6,462 - $20,293
1,352 Added 5.83%
24,533 $129,000
Q3 2022

Nov 14, 2022

BUY
$10.22 - $23.7 $236,909 - $549,389
23,181 New
23,181 $267,000
Q1 2022

May 12, 2022

SELL
$4.55 - $6.41 $87,332 - $123,033
-19,194 Closed
0 $0
Q4 2021

Feb 02, 2022

SELL
$5.89 - $9.73 $66,833 - $110,406
-11,347 Reduced 37.15%
19,194 $113,000
Q3 2021

Nov 12, 2021

SELL
$6.78 - $9.89 $264,542 - $385,888
-39,018 Reduced 56.09%
30,541 $261,000
Q2 2021

Aug 03, 2021

BUY
$7.24 - $11.2 $190,969 - $295,422
26,377 Added 61.08%
69,559 $561,000
Q1 2021

May 10, 2021

BUY
$8.05 - $20.78 $347,615 - $897,321
43,182 New
43,182 $465,000
Q3 2020

Nov 13, 2020

SELL
$2.58 - $3.36 $106,742 - $139,013
-41,373 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$2.58 - $4.58 $106,742 - $189,488
41,373 New
41,373 $135,000

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $56.9M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Oppenheimer & CO Inc Portfolio

Follow Oppenheimer & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.